Lauren P. Silvernail - 15 Sep 2022 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Director
Signature
/s/ Frank J. Lanza, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Sep 2022
Net transactions value
$0
Form type
4
Filing time
19 Sep 2022, 16:23:28 UTC
Previous filing
18 May 2022
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (right to buy) Award $0 +20,335 $0.000000 20,335 15 Sep 2022 Common Stock 20,335 $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in three equal annual installments measured from the date of grant, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.